Cargando…
Aggregation and analysis of indication-symptom relationships for drugs approved in the USA
PURPOSE: Drug indications and disease symptoms often confound adverse event reports in real-world datasets, including electronic health records and reports in the FDA Adverse Event Reporting System (FAERS). A thorough, standardized set of indications and symptoms is needed to identify these confound...
Autores principales: | Punyala, Ananth, Lankapalli, Rachana, Hindman, Diane, Racz, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419351/ https://www.ncbi.nlm.nih.gov/pubmed/32495081 http://dx.doi.org/10.1007/s00228-020-02898-w |
Ejemplares similares
-
Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008) -
Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015) -
Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany
por: Elsayed, Mohamed, et al.
Publicado: (2020) -
Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients
por: Belfrage, Björn, et al.
Publicado: (2015) -
Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)